VectorY Therapeutics, a biotech company developing disease-modifying vectorized antibody therapies for the treatment of ...

Bradford Smith became the third patient to test Elon Musk's Neuralink — and the first one to do so without a voice.

The approved ALS therapy Radicava may cause serious unexpected side effects, such as liver problems and blood clots, per U.S. FDA data.

Amyotrophic lateral sclerosis (ALS)—known as Lou Gehrig's Disease, based on the iconic 1930s New York Yankee baseball ...

Just four months after Eli Lilly and British biotech Alchemab penned a discovery collaboration, the Big Pharma is licensing ...

Eli Lilly will be licensing Alchemab Therapeutics’ preclinical programme for amyotrophic lateral sclerosis (ALS) and other ...

Brad Smith is the third person in the world to get a brain chip implant with Elon Musk's Neuralink, and the first nonverbal ...

Rebecca Gayheart and Eric Dane were spotted together after calling off their divorce amid the 'Euphoria' star's ALS diagnosis ...

Clene’s cash and cash equivalents totaled $9.8 million as of March 31, 2025, compared to $12.2 million as of December 31, 2024. Clene expects that its resources as of March 31, 2025, will be ...

Houston mortgage duo Cissy and Christopher Larkin are channeling a four-year ALS battle into a widespread fundraiser.

U.K.-based biotech Alchemab on Tuesday announced a licensing agreement with Eli Lilly (NYSE:LLY) to jointly develop ATLX-1282 ...

Wade Leming was diagnosed with this degenerative disease. His friends and family created a tradition called Wade's Day that ...